![]() |
市場調查報告書
商品編碼
1892808
眼科縫合線市場機會、成長促進因素、產業趨勢分析及預測(2026-2035年)Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
2025 年全球眼科縫合線市場價值為 11 億美元,預計到 2035 年將以 4.3% 的複合年成長率成長至 18 億美元。

眼科手術數量的增加、人口老化、技術創新、眼部疾病盛行率上升以及優質醫療保健服務的普及,共同推動了市場擴張。眼科縫合線為醫院、專科眼科診所和門診手術中心提供至關重要的手術解決方案,可改善患者預後,實現精準的傷口管理,並提高白內障、角膜、青光眼和視網膜手術的手術效率。這些縫合線,包括先進的可吸收和不可吸收縫合線,經過精心設計,具有優異的操作性能、最小的組織損傷和可靠的術後癒合,使眼科醫生能夠更精確、更安全地進行精細手術。顯微外科技術的進步以及門診和日間眼科手術的日益普及,增加了對能夠減少發炎、加速癒合並提供可預測恢復效果的縫合線的需求。新興經濟體醫療基礎設施的擴建和支出的成長也提高了患者接受矯正性眼科手術的機會,從而支撐了市場的持續成長。
| 市場範圍 | |
|---|---|
| 起始年份 | 2025 |
| 預測年份 | 2026-2035 |
| 起始值 | 11億美元 |
| 預測值 | 18億美元 |
| 複合年成長率 | 4.3% |
到2025年,合成縫合線市佔率預計將達到68.8%,這主要得益於其高拉伸強度、可預測的吸收性和廣泛的臨床應用。合成縫合線由聚乳酸-羥基乙酸共聚物、聚乙醇酸和聚二氧雜環己酮等材料製成,具有組織反應性低、感染或發炎風險小等優點,因此非常適合用於精細的眼科手術。
由於其可生物分解性和優異的抗張強度,PGA(聚乙醇酸)縫合線預計在2025年將佔據34.5%的市場佔有率,價值達6.07億美元。 PGA縫合線可在體內逐漸分解,無需取出,從而減輕患者不適,減少復診次數,尤其有利於兒科和老年患者。
2025年,北美眼科縫合線市佔率預計將達到38.1%,這主要得益於先進的醫療基礎設施、高昂的醫療支出以及眼部疾病盛行率的不斷上升。該地區擁有龐大的醫院、門診手術中心和專科眼科診所網路,進行大量的白內障、青光眼和視網膜手術,從而確保了對眼科縫合線的持續需求。
The Global Ophthalmic Sutures Market was valued at USD 1.1 billion in 2025 and is estimated to grow at a CAGR of 4.3% to reach USD 1.8 billion by 2035.

Market expansion is driven by the rising number of ophthalmic surgeries, an aging population, technological innovations, and increased prevalence of eye disorders, alongside broader access to quality healthcare. Ophthalmic sutures provide crucial surgical solutions to hospitals, specialty eye clinics, and ambulatory surgical centers, enhancing patient outcomes, precise wound management, and surgical efficiency in cataract, corneal, glaucoma, and retinal procedures. These sutures, including advanced absorbable and non-absorbable options, are engineered for superior handling, minimal tissue trauma, and reliable postoperative healing, enabling ophthalmologists to perform delicate surgeries with greater precision and safety. Advancements in microsurgical techniques and the growing trend toward outpatient and ambulatory ophthalmic procedures have increased demand for sutures that reduce inflammation, accelerate healing, and provide predictable recovery outcomes. Expanding healthcare infrastructure and rising expenditure in emerging economies are also improving patient access to corrective eye surgeries, supporting consistent market growth.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1.1 Billion |
| Forecast Value | $1.8 Billion |
| CAGR | 4.3% |
The synthetic segment held a 68.8% share in 2025, driven by high tensile strength, predictable absorption, and widespread clinical adoption. Synthetic sutures, composed of materials like polyglactin, polyglycolic acid, and polydioxanone, offer reduced tissue reactivity and minimal risk of infection or inflammation, making them highly suitable for delicate eye surgeries.
The PGA segment held a 34.5% share in 2025, valued at USD 607 million, due to its biodegradable properties and excellent tensile strength. PGA sutures degrade gradually in the body, eliminating the need for removal, reducing patient discomfort, and minimizing follow-up visits, particularly benefiting pediatric and geriatric patients.
North America Ophthalmic Sutures Market held a 38.1% share in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, and growing prevalence of eye disorders. The region's extensive network of hospitals, ambulatory surgical centers, and specialty eye clinics performing a high volume of cataract, glaucoma, and retinal procedures ensures sustained demand for ophthalmic sutures.
Key players in the Global Ophthalmic Sutures Market include Teleflex Incorporated, Assut Medical, Aurolab, Ethicon, Alcon, Corza Medical, Accutome, Mani, DemeTECH, FCI Ophthalmics, Geuder AG, Medtronic, B Braun, and Unilene. Companies in the Ophthalmic Sutures Market are strengthening their position through continuous product innovation, developing sutures with improved handling, biodegradability, and tensile strength. Strategic partnerships with hospitals, clinics, and distributors enable wider reach and faster adoption of new solutions. Expanding global footprints and entering emerging markets allow manufacturers to capture rising demand in underserved regions. Investment in R&D, clinical training programs, and after-sales support enhances brand loyalty, while regulatory compliance and quality certifications build trust among healthcare providers. Marketing initiatives, educational outreach, and digital engagement strategies further solidify their market presence and competitiveness.